Our research expands this paradigm by characterizing two additional CEBPE loci: rs4982731-C confers significant ALL risk, while rs2144827-A exhibits protective effects, suggesting complex haplotype-specific regulation of CEBPE’s leukemogenic potential. The gene discussed is CEBPE; the disease is acute lymphoblastic leukemia.